Attached files
file | filename |
---|---|
8-K/A - CURRENT REPORT - DS HEALTHCARE GROUP, INC. | dskx_8k.htm |
EX-99.1 - FINANCIAL STATEMENTS - DS HEALTHCARE GROUP, INC. | dskx_99z1.htm |
EXHIBIT 99.2
DS Healthcare Group, Inc.
Pro-Forma Consolidated Balance Sheet
September 30, 2012
|
| DS Healthcare Group, Inc. (Consolidated) |
|
| DS Laboratories, S.A. DE C.V. |
|
| Acquisition Adjustment |
| Acquisition |
| Elimination |
| ProForma Consolidated Balance Sheet |
| ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
Current Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
Cash |
| $ | 945,065 |
|
| $ | 70,762 |
|
|
|
|
|
|
|
|
|
|
|
|
| $ | 1,015,827 |
| ||
Accounts receivable, net |
|
| 2,575,231 |
|
|
| 392,323 |
|
|
|
|
|
|
|
|
|
| (255,676 | ) | (c) |
|
| 2,711,878 |
| |
Inventory |
|
| 2,920,721 |
|
|
| 249,296 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3,170,017 |
| |
Prepaid expenses and other current assets |
|
| 1,766,397 |
|
|
| 203,550 |
|
|
| (1,500,000 | ) | (a) |
|
|
|
|
|
|
|
|
|
| 469,947 |
|
Total Current Assets |
|
| 8,207,414 |
|
|
| 915,931 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 7,367,669 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Furniture and Equipment, net |
|
| 111,727 |
|
|
| 110,112 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 221,839 |
|
Intangible Assets, net |
|
| 653,741 |
|
|
| |
|
|
| 1,482,227 |
| (a) |
| (492,147 | )(d) |
|
|
|
|
|
|
| 1,643,821 |
|
Other Assets |
|
| 67,431 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 67,431 |
|
TOTAL ASSETS |
| $ | 9,040,313 |
|
| $ | 1,026,043 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| $ | 9,300,760 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses |
| $ | 1,432,191 |
|
| $ | 374,192 |
|
|
|
|
|
|
|
|
|
|
| (255,676 | ) | (c) |
| $ | 1,550,707 |
|
Client facility |
|
| 602,298 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 602,298 |
|
Taxes payable |
|
| |
|
|
| 7,718 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 7,718 |
|
Deferred income taxes |
|
| |
|
|
| 76,871 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 76,871 |
|
Other current liabilities |
|
| 126,708 |
|
|
| 49,489 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 176,197 |
|
TOTAL LIABILITIES |
|
| 2,161,197 |
|
|
| 508,270 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2,413,791 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COMMITMENTS AND CONTINGENCIES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, $0.001 par value, 30 million shares authorized: 5,500,000 shares issued and outstanding at September 30, 2012 |
|
| 5,500 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5,500 |
|
Common stock, $0.001 par value, 300 million shares authorized: 120,779,442 shares issued and outstanding at September 30, 2012 |
|
| 120,779 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 120,779 |
|
Additional paid-in-capital |
|
| 9,692,871 |
|
|
| 118,300 |
|
|
| (118,300 | ) | (a) |
|
|
|
|
|
|
|
|
|
| 9,692,871 |
|
Legal reserve |
|
|
|
|
|
| 12,130 |
|
|
| (12,130 | ) | (a) |
|
|
|
|
|
|
|
|
|
| |
|
Stock subscription |
|
| (600,000 | ) |
|
| |
|
|
| 500,000 |
| (a) |
|
|
|
|
|
|
|
|
|
| (100,000 | ) |
Other comprehensive income |
|
| |
|
|
| 9,910 |
|
|
| (9,910 | ) | (a) |
|
|
|
|
|
|
|
|
|
| |
|
Retained earnings (accumulated deficit) |
|
| (2,340,034 | ) |
|
| 377,433 |
|
|
| (377,433 | ) | (a) |
| (492,147 | )(d) |
|
|
|
|
|
|
| (2,832,181 | ) |
Total Shareholders' Equity |
|
| 6,879,116 |
|
|
| 517,773 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 6,886,969 |
|
Non-Controlling Interest |
|
| |
|
|
| |
|
|
|
|
|
|
| 2,140 | (b) |
|
|
|
|
|
|
| 2,140 |
|
Total Equity |
|
| 6,879,116 |
|
|
| 517,773 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 6,884,829 |
|
TOTAL LIABILITIES AND EQUITY |
| $ | 9,040,313 |
|
| $ | 1,026,043 |
|
|
| |
|
|
| |
|
|
| |
|
|
| $ | 9,300,760 |
|
(a)
To reclass initial purchase price of $2,000,000, record intangible asset associated with customer list and reverse equity for subsidiary purchased.
(b)
To reflect 1% noncontrolling interest.
(c)
To record intercompany eliminations.
(d)
To record amortization of the customer list from January 1, 2011 through September 30, 2012 based on a 5 year amortization period.
PF-1
DS Healthcare Group, Inc.
Pro-Forma Consolidated Statement of Operations
For the year ended December 31, 2011
|
| DS Healthcare Group, Inc. (Consolidated) |
|
| DS Laboratories, S.A. DE C.V. |
|
| Eliminations |
| ProForma Consolidated Statement of Operations |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Net Revenues |
| $ | 9,672,861 |
|
| $ | 1,145,219 |
|
|
| (559,674 | ) | (a) |
| $ | 10,258,406 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of Goods Sold |
|
| 4,751,961 |
|
|
| 547,067 |
|
|
| (559,674 | ) | (a) |
|
| 4,739,354 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit |
|
| 4,920,900 |
|
|
| 598,152 |
|
|
|
|
|
|
|
| 5,519,052 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Costs and Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling and marketing |
|
| 2,856,482 |
|
|
| |
|
|
|
|
|
|
|
| 2,856,482 |
|
General and administrative |
|
| 3,057,988 |
|
|
| 350,793 |
|
|
| 281,227 |
| (b) |
|
| 3,690,008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating costs and expenses |
|
| 5,914,470 |
|
|
| 350,793 |
|
|
|
|
|
|
|
| 6,546,490 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Income (Loss) |
|
| (993,570 | ) |
|
| 247,359 |
|
|
|
|
|
|
|
| (1,027,438 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Income (Expense) |
|
| 12,678 |
|
|
| 16,771 |
|
|
|
|
|
|
|
| (4,093) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) before income tax |
|
| (980,892 | ) |
|
| 230,588 |
|
|
|
|
|
|
|
| (1,031,531 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax |
|
| |
|
|
| 46,118 |
|
|
|
|
|
|
|
| 46,118 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss) |
|
| (980,892 | ) |
|
| 184,470 |
|
|
|
|
|
|
|
| (1,077,649 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss) Attributable to Non-Controlling Interest |
| $ | (2,292 | ) |
| $ | 1,845 |
|
|
|
|
|
|
| $ | (447 | ) |
Net Income (Loss) Attributable to Shareholders of DS Healthcare Group, Inc. |
| $ | (978,600 | ) |
| $ | 182,625 |
|
|
|
|
|
|
| $ | (1077,202 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted Earnings per Share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares |
|
| 100,611,200 |
|
|
|
|
|
|
|
|
|
|
|
| 100,611,200 |
|
Earnings per share |
| $ | (0.01 | ) |
|
|
|
|
|
|
|
|
|
| $ | (0.01 | ) |
(a)
To eliminate intercompany sales and purchases.
(b)
To record twelve months amortization of the customer list based upon a 5 year amortization period.
PF-2
DS Healthcare Group, Inc.
Pro-Forma Consolidated Statement of Operations
For the nine months ended September 30, 2012
|
| DS Healthcare Group, Inc. (Consolidated) |
|
| DS Laboratories, S.A. DE C.V. |
|
| Eliminations |
| ProForma Consolidated Statement of Operations |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Net Revenues |
| $ | 8,672,634 |
|
| $ | 1,334,820 |
|
|
| (343,730 | ) | (a) |
| $ | 9,663,724 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Cost of Goods Sold |
|
| 4,380,170 |
|
|
| 416,398 |
|
|
| (343,730 | ) | (a) |
|
| 4,452,838 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit |
|
| 4,292,464 |
|
|
| 918,422 |
|
|
|
|
|
|
|
| 5,210,886 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Costs and Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling and marketing |
|
| 2,536,197 |
|
|
| |
|
|
|
|
|
|
|
| 2,536,197 |
|
General and administrative |
|
| 2,609,990 |
|
|
| 639,569 |
|
|
| 210,920 |
| (b) |
|
| 3,460,479 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating costs and expenses |
|
| 5,146,187 |
|
|
| 639,569 |
|
|
|
|
|
|
|
| 5,996,676 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Income (Loss) |
|
| (853,723 | ) |
|
| 278,853 |
|
|
|
|
|
|
|
| (785,790 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Income |
|
| 4,937 |
|
|
| 12,035 |
|
|
|
|
|
|
|
| 16,972 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) before income tax |
|
| (848,786 | ) |
|
| 290,888 |
|
|
|
|
|
|
|
| (768,818 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax |
|
| |
|
|
| 76,871 |
|
|
|
|
|
|
|
| 76,871 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss) |
|
| (848,786 | ) |
|
| 214,017 |
|
|
|
|
|
|
|
| (845,689 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss) Attributable to Non-Controlling Interest |
| $ | |
|
| $ | 2,140 |
|
|
|
|
|
|
| $ | 2,140 |
|
Net Income (Loss) Attributable to Shareholders of DS Healthcare Group, Inc. |
| $ | (848,786 | ) |
| $ | 211,877 |
|
|
|
|
|
|
| $ | (843,549 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted Earnings per Share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares |
|
| 107,784,752 |
|
|
|
|
|
|
|
|
|
|
|
| 107,784,752 |
|
Earnings per share |
| $ | (0.01 | ) |
|
|
|
|
|
|
|
|
|
| $ | (0.01 | ) |
(a)
To eliminate intercompany sales and purchases.
(b)
To record nine months amortization of the customer list based on a 5 year amortization period.
PF-3